Spruce Biosciences, Inc. (SPRB)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.0150 (15.79%)
Jul 18, 2025, 4:00 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $4.65 million as of July 18, 2025. Its market cap has decreased by -78.59% in one year.
Market Cap
4.65M
Enterprise Value
-18.67M
Revenue
2.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from 378.48M to 4.65M, a decrease of -98.77%. That is a compound annual growth rate of -60.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 4.65M | -73.22% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.61B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 599.09M |
| Glass House Brands | 434.24M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 386.15M |